Femasys Inc
NASDAQ:FEMY
Femasys Inc
Total Liabilities
Femasys Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Total Liabilities
$9.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities
$28.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities
$16.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities
$20.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities
$33.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities
$1.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
See Also
What is Femasys Inc's Total Liabilities?
Total Liabilities
9.4m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Total Liabilities amounts to 9.4m USD.
What is Femasys Inc's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
32%
Over the last year, the Total Liabilities growth was 470%. The average annual Total Liabilities growth rates for Femasys Inc have been 32% over the past three years .